- Is Contrave the new weight loss drug leader? An emergency Ebola test and new pregnancy information in 2015 - Thu, 09/10/2015
- Generic Lexapro (escitalopram) approved by the FDA - Wed, 03/14/2012
- Gintuit- the first cell-based FDA approval for mucogingival problems - Fri, 03/09/2012
- 5th surfactant (lucinactant) for respiratory distress syndrome (RDS) in premature infants approved by the FDA today - Tue, 03/06/2012
- FluMist Quadrivalent--four virus types in one spray--the benefit of no shot, but you can't be 50 - Wed, 02/29/2012
- The first Helicobacter pylori breath test in children (BreathTek UBT) - Fri, 02/24/2012
- No preservative in Zioptan (tafluprost) glaucoma drug from Merck may be a distinct advantage - Tue, 02/14/2012
- Important new treatment for the most common skin cancer (basal cell carcinoma) called Erivedge ( vismodegib ) - Mon, 01/30/2012
- New orphan drug (clobazam-Onfi) approved for Lennox-Gastaut seizures - Mon, 10/24/2011
- Juvisync in sync for diabetes and cholesterol problems - Tue, 10/11/2011
- Yervoy (ipilimumab) approved for melanoma by the FDA - Fri, 03/25/2011
- Waiting for weight loss and Contrave - Mon, 01/31/2011
- Medicine absorbed from the mouth--the latest in cancer pain - Fri, 01/07/2011
- Amturnide and three drugs in one for high blood pressure - Wed, 12/22/2010
- Got Pain ?...Cymbalta may help - Thu, 11/11/2010
- Kombiglyze combination treatment for type 2 diabetes - Fri, 11/05/2010
- New antibiotic fights even resistant bacteria in lungs and skin - Fri, 10/29/2010
- Pradaxa Promise - Tue, 10/19/2010
- Knowing Livalo (pitavastatin) - Tue, 08/03/2010
- Qnexa FDA weight loss pill NOT recommended for approval by committee-July 15, 2010 - Thu, 07/15/2010
- Onglyza (generic name: saxagliptin) - Fri, 07/31/2009
- Will lorcaserin (Lorquess) survive FDA scrutiny? -
- FDA rejects another weight loss drug -
- Is the PRESENT study the key for a new vaccine for breast cancer? -
-
Lorcaserin (Lorqess) leaving the FDA launching pad? -